NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Neurofibromatosis type 2 (NF2) is an autosomal-dominant disorder linked to NF2 gene mutations, leading to nervous system tumors.
• Identifying germline mutations in NF2 is crucial for genetic counseling but difficult due to mutation heterogeneity and mosaicism.
• Existing screening techniques are often insufficient for comprehensive NF2 mutation detection.

Purpose of the Study:

• To develop and evaluate efficient methods for detecting point mutations and gene rearrangements in the NF2 gene.
• To improve the diagnostic yield for Neurofibromatosis type 2 patients.

Main Methods:

• Developed a semi-automated denaturing high-performance liquid chromatography (DHPLC) method for point mutation detection.
• Utilized multiplex ligation-dependent probe amplification (MLPA) to screen for NF2 gene rearrangements.
• Evaluated high-resolution melting analysis (HRMA) for NF2 exon scanning and point mutation identification.

Main Results:

• Successfully applied DHPLC and MLPA in analyzing 92 NF2 patients.
• Expanded the known spectrum of NF2 mutations.
• DHPLC and HRMA demonstrated effectiveness in screening for NF2 point mutations.

Conclusions:

• DHPLC combined with MLPA offers an efficient approach for comprehensive NF2 mutation screening.
• HRMA serves as a valuable tool for exon scanning to detect point mutations in the NF2 gene.
• These methods enhance the ability to diagnose NF2, particularly in cases with diverse genetic alterations.